...
首页> 外文期刊>Hormone and Metabolic Research >Treatment with the nitric oxide donor SNP increases triiodothyronine levels in hyper- and hypothyroid sprague-dawley rats
【24h】

Treatment with the nitric oxide donor SNP increases triiodothyronine levels in hyper- and hypothyroid sprague-dawley rats

机译:一氧化氮供体SNP的治疗可增加甲状腺功能亢进和甲状腺功能减退大鼠的三碘甲状腺素水平

获取原文
获取原文并翻译 | 示例
           

摘要

Nitric oxide pathway might play a crucial role in the pathophysiology of thyroid dysfunctions. This study aimed to investigate the impact of nitric oxide (NO) on hypothyroid and hyperthyroid Sprague-Dawley rats under controlled diet. Furthermore, the effects of the nitric oxide donor sodium nitroprusside (SNP) on thyroid dysfunctions were also assessed. Sprague-Dawley rats (n=107) were subdivided into normal diet and high-fat diet (HFD) groups and grouped into controls, hypothyroid, hyperthyroid, and SNP treated groups. Hypothyroidism was induced through propylthiouracil, whereas hyperthyroidism by triiodothyronine (T3). After 12 weeks of T3 treatment, serum nitric oxides (NOX), endogenous asymmetric dimethylarginine (ADMA), body weight and food intake were analyzed. Hypothyroid rats showed decreased serum T3 levels, hyperthyroid rats increased T3 compared to controls. Diet had no impact on T3. Thyroid dysfunctions were accompanied by changes in calorie intake and body weight. Serum NOX was significantly reduced in normal diet hypothyroid rats. SNP administration compensated the decrease and markedly increased T3. NO synthase inhibitor ADMA levels were significantly higher in the HFD control group than in the normal diet controls. ADMA was declined in both hypothyroid groups and increased in normal diet hyperthyroid rats. An association of thyroid dysfunctions with reduced bioavailability of NO and alterations of ADMA levels could be established. Treatment with the NO donor SNP resulted in an increase of serum T3 levels. These results demonstrate that the NO pathway is implicated in thyroid dysfunctions, which may be of clinical relevance.
机译:一氧化氮途径可能在甲状腺功能异常的病理生理中起关键作用。本研究旨在探讨一氧化氮(NO)对节食饮食对甲状腺功能减退和甲状腺功能亢进的Sprague-Dawley大鼠的影响。此外,还评估了一氧化氮供体硝普钠(SNP)对甲状腺功能障碍的影响。将Sprague-Dawley大鼠(n = 107)分为正常饮食和高脂饮食(HFD)组,并分为对照组,甲状腺功能减退,甲状腺功能亢进和SNP治疗组。甲状腺功能减退症是通过丙基硫氧嘧啶引起的,而甲状腺功能亢进症是由三碘甲状腺素(T3)引起的。在T3治疗12周后,分析了血清一氧化氮(NOX),内源性不对称二甲基精氨酸(ADMA),体重和食物摄入量。与对照组相比,甲状腺功能减退的大鼠显示血清T3水平降低,甲状腺功能亢进的大鼠增加T3。饮食对T3没有影响。甲状腺功能障碍伴有卡路里摄入和体重的变化。正常饮食甲状腺功能减退大鼠的血清NOX明显降低。 SNP管理弥补了T3的下降并明显增加。 HFD对照组的NO合酶抑制剂ADMA水平明显高于正常饮食对照组。甲状腺功能减退组的ADMA均下降,正常饮食甲状腺功能亢进的大鼠ADMA升高。可以确定甲状腺功能障碍与NO生物利用度降低和ADMA水平改变之间的关联。用NO供体SNP治疗导致血清T3水平升高。这些结果表明,NO途径与甲状腺功能障碍有关,这可能与临床有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号